Back to Browse Journals » Pharmacogenomics and Personalized Medicine » Volume 5

Individualization of antiretroviral therapy

Authors Pavlos R, Phillips EJ

Published Date December 2011 Volume 2012:5 Pages 1—17

DOI http://dx.doi.org/10.2147/PGPM.S15303

Published 29 December 2011

Rebecca Pavlos, Elizabeth J Phillips
Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia

Abstract: Antiretroviral therapy (ART) has evolved considerably over the last three decades. From the early days of monotherapy with high toxicities and pill burdens, through to larger pill burdens and more potent combination therapies, and finally, from 2005 and beyond where we now have the choice of low pill burdens and once-daily therapies. More convenient and less toxic regimens are also becoming available, even in resource-poor settings. An understanding of the individual variation in response to ART, both efficacy and toxicity, has evolved over this time. The strong association of the major histocompatibility class I allele HLA-B*5701 and abacavir hypersensitivity, and its translation and use in routine HIV clinical practice as a predictive marker with 100% negative predictive value, has been a success story and a notable example of the challenges and triumphs in bringing pharmacogenetics to the clinic. In real clinical practice, however, it is going to be the exception rather than the rule that individual biomarkers will definitively guide patient therapy. The need for individualized approaches to ART has been further increased by the importance of non-AIDS comorbidities in HIV clinical practice. In the future, the ideal utilization of the individualized approach to ART will likely consist of a combined approach using a combination of knowledge of drug, virus, and host (pharmacogenetic and pharmacoecologic [factors in the individual's environment that may be dynamic over time]) information to guide the truly personalized prescription. This review will focus on our knowledge of the pharmacogenetics of the efficacy and toxicity of currently available antiretroviral agents and the current and potential utility of such information and approaches in present and future HIV clinical care.

Keywords: HIV, pharmacogenetics, pharmacogenomics, personalized medicine, antiretroviral

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Pharmacogenetic information for patients on drug labels

Haga SB, Mills R, Moaddeb J

Pharmacogenomics and Personalized Medicine 2014, 7:297-305

Published Date: 3 October 2014

Therapeutic efficiency of folated poly(ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer

Kim YK, Minai-Tehrani A, Lee JH, Cho CS, Cho MH, Jiang HL

International Journal of Nanomedicine 2013, 8:1489-1498

Published Date: 16 April 2013

An MRI-visible non-viral vector for targeted Bcl-2 siRNA delivery to neuroblastoma

Shen M, Gong FM, Pang PF, Zhu KS, Meng XC, Wu C, Wang J, Shan H, Shuai XT

International Journal of Nanomedicine 2012, 7:3319-3332

Published Date: 2 July 2012

Josef Jadassohn (1863–1936), Felix Lewandowsky (1879–1921), and their syndrome

Al Aboud A, Al Aboud K

Clinical, Cosmetic and Investigational Dermatology 2011, 4:179-182

Published Date: 6 December 2011

Non-invasive and transdermal measurement of blood uric acid level in human by electroporation and reverse iontophoresis

Chih-Kuei Lee, Congo Tak-Shing Ching, Tai-Ping Sun, et al

International Journal of Nanomedicine 2010, 5:991-997

Published Date: 19 November 2010

The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia

Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, et al

International Journal of Nanomedicine 2010, 5:581-591

Published Date: 6 August 2010

Management of COPD in general practice in Denmark – participating in an educational program substantially improves adherence to guidelines

Charlotte Suppli Ulrik, Ejvind Frausing Hansen, Michael Skov Jensen, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:73-79

Published Date: 11 March 2010

Tinidazole in the treatment of bacterial vaginosis

Nicola R Armstrong, Janet D Wilson

International Journal of Women's Health 2009, 1:59-65

Published Date: 25 June 2009

Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles

James Chen Yong Kah, Kiang Wei Kho, Caroline Guat Leng Lee, Colin James Richard Sheppard, Ze Xiang Shen, et al

International Journal of Nanomedicine 2007, 2:785-798

Published Date: 28 January 2007